304 related articles for article (PubMed ID: 23644884)
21. Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.
Vanaja GR; Ramulu HG; Kalle AM
Cell Commun Signal; 2018 May; 16(1):20. PubMed ID: 29716651
[TBL] [Abstract][Full Text] [Related]
22. A novel GRK2/HDAC6 interaction modulates cell spreading and motility.
Lafarga V; Aymerich I; Tapia O; Mayor F; Penela P
EMBO J; 2012 Feb; 31(4):856-69. PubMed ID: 22193721
[TBL] [Abstract][Full Text] [Related]
23. HDAC6 is a microtubule-associated deacetylase.
Hubbert C; Guardiola A; Shao R; Kawaguchi Y; Ito A; Nixon A; Yoshida M; Wang XF; Yao TP
Nature; 2002 May; 417(6887):455-8. PubMed ID: 12024216
[TBL] [Abstract][Full Text] [Related]
24. The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis.
Lee YS; Lim KH; Guo X; Kawaguchi Y; Gao Y; Barrientos T; Ordentlich P; Wang XF; Counter CM; Yao TP
Cancer Res; 2008 Sep; 68(18):7561-9. PubMed ID: 18794144
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
Meng F; Sun G; Zhong M; Yu Y; Brewer MA
Int J Oncol; 2013 Aug; 43(2):495-502. PubMed ID: 23709006
[TBL] [Abstract][Full Text] [Related]
26. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
Li G; Jiang H; Chang M; Xie H; Hu L
J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170
[TBL] [Abstract][Full Text] [Related]
27. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M
Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142
[TBL] [Abstract][Full Text] [Related]
28. The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease.
Batchu SN; Brijmohan AS; Advani A
Clin Sci (Lond); 2016 Jun; 130(12):987-1003. PubMed ID: 27154743
[TBL] [Abstract][Full Text] [Related]
29. Effect of EGF-induced HDAC6 activation on corneal epithelial wound healing.
Wang J; Lin A; Lu L
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2943-8. PubMed ID: 20089874
[TBL] [Abstract][Full Text] [Related]
30. HDAC6 deacetylates alpha tubulin in sperm and modulates sperm motility in Holtzman rat.
Parab S; Shetty O; Gaonkar R; Balasinor N; Khole V; Parte P
Cell Tissue Res; 2015 Feb; 359(2):665-678. PubMed ID: 25411052
[TBL] [Abstract][Full Text] [Related]
31. Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly.
Ran J; Yang Y; Li D; Liu M; Zhou J
Sci Rep; 2015 Aug; 5():12917. PubMed ID: 26246421
[TBL] [Abstract][Full Text] [Related]
32. Extracellular signal-regulated kinase (ERK) phosphorylates histone deacetylase 6 (HDAC6) at serine 1035 to stimulate cell migration.
Williams KA; Zhang M; Xiang S; Hu C; Wu JY; Zhang S; Ryan M; Cox AD; Der CJ; Fang B; Koomen J; Haura E; Bepler G; Nicosia SV; Matthias P; Wang C; Bai W; Zhang X
J Biol Chem; 2013 Nov; 288(46):33156-70. PubMed ID: 24089523
[TBL] [Abstract][Full Text] [Related]
33. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
Yu J; Ma Z; Shetty S; Ma M; Fu J
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
[TBL] [Abstract][Full Text] [Related]
34. Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6.
Qu X; Du J; Zhang C; Fu W; Xi H; Zou J; Hou J
PLoS One; 2012; 7(2):e32215. PubMed ID: 22384180
[TBL] [Abstract][Full Text] [Related]
35. The histone deacetylase-6 inhibitor tubacin directly inhibits de novo sphingolipid biosynthesis as an off-target effect.
Siow D; Wattenberg B
Biochem Biophys Res Commun; 2014 Jul; 449(3):268-71. PubMed ID: 24835950
[TBL] [Abstract][Full Text] [Related]
36. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
Beyer M; Kiweler N; Mahboobi S; Krämer OH
Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells.
Asthana J; Kapoor S; Mohan R; Panda D
J Biol Chem; 2013 Aug; 288(31):22516-26. PubMed ID: 23798680
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Expression and Functions of Histone Deacetylase 6 (HDAC6).
Li M; Zhuang Y; Shan B
Methods Mol Biol; 2016; 1436():85-94. PubMed ID: 27246209
[TBL] [Abstract][Full Text] [Related]
39. SIRT2 inactivation reveals a subset of hyperacetylated perinuclear microtubules inaccessible to HDAC6.
Skoge RH; Ziegler M
J Cell Sci; 2016 Aug; 129(15):2972-82. PubMed ID: 27311481
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344.
Dawood M; Fleischer E; Klinger A; Bringmann G; Shan L; Efferth T
Pharmacol Res; 2020 Oct; 160():105076. PubMed ID: 32659428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
